// App-Quantinova.ai

e19024 : Low incidence of hepatic veno-occlusive disease (VOD) in patients with B-cell acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin (INO) followed by allogeneic stem cell transplantation (allo-SCT).

Researchers

Presenter

  • Kirk Cahill

Principal Investigators

  • Juan Alban

  • Mylove Mortel

  • Emily Dworkin

  • Satyajit Kosuri

  • Adam Duvall

  • Hongtao Liu

  • Michael Russell Bishop

  • Richard A. Larson

  • Wendy Stock

Medical Centers

  • Section of Urology, Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, IL

  • Department of Medicine, University of Chicago, Chicago

  • Department of Pediatrics, University of Chicago Medical Center, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • B-cell acute lymphoblastic leukemia

  • Hepatic veno-occlusive disease with immunodeficiency

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Inotuzumab ozogamicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved